Personalizing induction therapy in kidney transplantation

被引：0
|
作者：
Meredith J. Aull
Manikkam Suthanthiran
机构：
[1] New York Presbyterian—Weill Cornell Medical College,Department of Surgery
[2] New York Presbyterian—Weill Cornell Medical College,Department of Medicine & Transplantation Medicine
来源：
Nature Reviews Nephrology | 2009年 / 5卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Induction therapy with rabbit anti-thymocyte globulin is preferable to induction with daclizumab in renal transplant recipients at high immunological risk. These findings provide additional support to the idea that personalized immunosuppressive regimens should be developed in renal transplant recipients.
引用
收藏
页码：619 / 620
页数：1
相关论文
共 50 条
  • [41] Kidney Transplantation Using Alemtuzumab Induction and Belatacept/Sirolimus Maintenance Therapy.
    Kirk, A. D.
    Mead, S.
    Xu, H.
    Mehta, A.
    Guasch, A.
    Cheeseman, J.
    Joseph, J.
    Horan, J.
    Kean, L.
    Larsen, C. P.
    Pearson, T. C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 45 - 45
  • [42] Safety and Efficacy of Induction Therapy With Thymoglobulin in ABO-Incompatible Kidney Transplantation
    Herzog, A. L.
    Kalogirou, C.
    Wanner, C.
    Lopau, K.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (01) : 53 - 59
  • [43] Induction Immunosuppresive Therapy for Kidney Transplantation in Elderly Recipients: A Single Center Experience
    Reyad, Ashraf
    Allam, Sridhar
    El-Hag, Amanda
    Ann Dao
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 47 - 48
  • [44] Efficacy and safety of induction therapy with alemtuzumab in kidney transplantation: a meta-analysis
    Shou Zhang-fei
    Zhou Qin
    Cai Jie-ru
    Cheng Jun
    He Qiang
    Wu Jian-yong
    Chen Jiang-hua
    CHINESE MEDICAL JOURNAL, 2009, 122 (14) : 1692 - 1698
  • [45] Basiliximab or Antithymocyte Globulin for Induction Therapy in Kidney Transplantation: A Meta-analysis
    Liu, Y.
    Zhou, P.
    Han, M.
    Xue, C-B
    Hu, X-P
    Li, C.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (05) : 1667 - 1670
  • [46] Induction Therapy in Simultaneous Pancreas-Kidney Transplantation: Thymoglobulin Versus Basiliximab
    Fernandez-Burgos, I.
    Montiel Casado, M. C.
    Perez-Daga, J. A.
    Aranda-Narvaez, J. M.
    Sanchez-Parez, B.
    Leon-Diaz, F. J.
    Cabello-Diaz, M.
    Rodriguez-Burgos, D.
    Hernandez-Marrero, D.
    Santoyo-Santoyo, J.
    TRANSPLANTATION PROCEEDINGS, 2015, 47 (01) : 120 - 122
  • [47] Non induction therapy in low risk living related kidney transplantation in India
    Kulkarni, Sudhir G.
    Gadekar, Kshitija G.
    Paike, Nilrohit B.
    Bhange, Nilesh
    Mahajan, Abhay
    Amlani, Dhruti
    TRANSPLANTATION, 2016, 100 (07) : S699 - S700
  • [48] MALIGNANCY COMPLICATIONS AFTER KIDNEY TRANSPLANTATION, SHOULD WE USE INDUCTION THERAPY?
    Molina, Maria
    Gonzalez, Esther
    Cabrera, Jimena
    Hernandez, Ana
    Polanco, Natalia
    Gutierrez, Eduardo
    Morales, Enrique
    Praga, Manuel
    Andres, Amado
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 : 1602 - 1602
  • [49] Alemtuzumab Induction Therapy in Kidney Transplantation: a Systematic Review and Meta-Analysis
    Morgan, R. D.
    O'Callaghan, J. M.
    Knight, S. K.
    Morris, P. J.
    TRANSPLANTATION, 2012, 94 (10) : 972 - 972
  • [50] Alemtuzumab Induction Therapy in Kidney Transplantation: A Systematic Review and Meta-Analysis
    Morgan, Robert D.
    O'Callaghan, John M.
    Knight, Simon R.
    Morris, Peter J.
    TRANSPLANTATION, 2012, 93 (12) : 1179 - 1188
12345